Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00782548Phase 4Completed
Phase 4, randomised, double-blind trial of morphine in pain (2 arms), sponsored by Allergan. Primary endpoint: Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide. Started May 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00782548.